IVF vs TCMD
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 17, 2026
IVF
TCMD
Investment Advisor Scores
TCMD
AI Analyst Insights
Detailed Metrics Comparison
| Metric | IVF | TCMD | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 19.1205 | Tie |
| PEG Ratio | 0 | 17.792 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 23.1% | 22.8% | IVF |
| Earnings Growth | 0.0% | 17.6% | TCMD |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 47.5/100 | 55.3/100 | TCMD |
| Profit Margin | -158.7% | 5.9% | TCMD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
IVF
MarkdownPrice below a falling SMA50 (slope -17.3%), weak momentum, RSI 36
TCMD
MarkupPrice above SMA50, rising 50-day trend (7.4% over 20 days), RSI 57
Fundamentals Snapshot
| Metric | IVF | TCMD |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -0.1 | 18.7 |
| Trailing P/E | 0.0 | 31.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.2% |
| Gross Margin | 0.4% | 0.8% |
| Operating Margin | -0.8% | 0.0% |
| EPS | 254.30 | 0.90 |
| Dividend Yield | — | — |